TABLE 4

Univariate and multivariable Cox model results describing associations between baseline clinical variables and progression-free survival

Hazard ratio95% CIp-value
Univariate analysis
 New York Heart Association stage2.0831.250–3.4700.0048#
 Mean pulmonary arterial pressure (mmHg)1.0391.013–1.0650.0028#
 Pulmonary capillary pressure (mmHg)1.0430.923–1.1800.4969
 Cardiac output (L·min−1)1.2670.996–1.6120.0535#
 Pulmonary vascular resistance (Wood's units)1.0080.952–1.0670.7796
 Right atrium pressure (mmHg)1.1941.048–1.3590.0075#
 6-min walk test
  Distance (m)0.9960.993–0.9990.0080#
  Distance (m) >440 m versus ≤440 m0.3980.166–0.9540.0389#
  Borg test1.0060.858–1.1790.9421
 Cardiac frequency (bpm)
  Baseline1.0040.947–1.0640.9011
  End1.0180.985–1.0530.2852
 Oxygen saturation (%)
  Baseline0.8960.821–0.9770.0132#
  End0.9370.902–0.9740.0010#
  Δ≥4%4.1440.534–32.160.1739
 SF-36 Questionnaire
  Physical functioning0.9810.966–0.9960.0142#
  Role-physical0.9860.975–0.9980.0212#
  Bodily pain0.9910.975–1.0080.3053
  General health0.9870.965–1.0090.2436
  Vitality0.9770.953–1.0020.0705#
  Social functioning0.9830.968–0.9980.0304#
  Role-emotional0.9880.978–0.9980.0199#
  Mental health0.9760.955–0.9970.0267#
Multivariate analysis
 SF-36 Questionnaire: physical functioning0.9780.962–0.9950.0106
 Mean pulmonary arterial pressure (mmHg)1.0531.023–1.0840.0153
 Cardiac output (L·min−1)1.5591.189–2.0450.0013

Δ≥4%: change in oxygen saturation over 4%; SF-36: 36-item Short-Form Health Survey. #: variables with a univariate p<0.15 were retained for multivariable analysis.